Genetics of Lumbar Disk Degeneration: Technology, Study Designs, and Risk Factors

Lumbar disk degeneration (LDD) is a common musculoskeletal condition. Genetic risk factors have been suggested to play a major role in its cause. This article reviews the main research strategies that have been used to study the genetics of LDD, and the genes that thus far have been identified to influence susceptibility to LDD. With the rapid progress in genomic technologies, further advances in the genetics of LDD are expected in the next few years. © 2011 Elsevier Inc.postprin

Deciphering osteoarthritis genetics across 826,690 individuals from 9 populations

Osteoarthritis affects over 300 million people worldwide. Here, we conduct a genome-wide association study meta-analysis across 826,690 individuals (177,517 with osteoarthritis) and identify 100 independently associated risk variants across 11 osteoarthritis phenotypes, 52 of which have not been associated with the disease before. We report thumb and spine osteoarthritis risk variants and identify differences in genetic effects between weight-bearing and non-weight-bearing joints. We identify sex-specific and early age-at-onset osteoarthritis risk loci. We integrate functional genomics data from primary patient tissues (including articular cartilage, subchondral bone, and osteophytic cartilage) and identify high-confidence effector genes. We provide evidence for genetic correlation with phenotypes related to pain, the main disease symptom, and identify likely causal genes linked to neuronal processes. Our results provide insights into key molecular players in disease processes and highlight attractive drug targets to accelerate translation

Altered Activation of Innate Immunity Associates with White Matter Volume and Diffusion in First-Episode Psychosis

First-episode psychosis (FEP) is associated with inflammatory and brain structural changes, but few studies have investigated whether systemic inflammation associates with brain structural changes in FEP. Thirty-seven FEP patients (median 27 days on antipsychotic medication), and 19 matched controls were recruited. Serum levels of 38 chemokines and cytokines, and cardiovascular risk markers were measured at baseline and 2 months later. We collected T1-and diffusion-weighted MRIs with a 3 T scanner from the patients at baseline. We analyzed the association of psychosis-related inflammatory markers with gray and white matter (WM) volume using voxel-based morphometry and WM diffusion using tract-based spatial statistics with whole-brain and region-of-interest (ROI) analyses. FEP patients had higher CCL22 and lower TGFa, CXCL1, CCL7, IFN-alpha 2 and ApoA-I than controls. CCL22 decreased significantly between baseline and 2 months in patients but was still higher than in controls. The association between inflammatory markers and FEP remained significant after adjusting for age, sex, smoking and BMI. We did not observe a correlation of inflammatory markers with any symptoms or duration of antipsychotic treatment. Baseline CCL22 levels correlated negatively with WM volume and positively with mean diffusivity and radial diffusivity bilaterally in the frontal lobes in ROI analyses. Decreased serum lan association between circulating chemokine levels and WM in FEP patients. Interestingly, CCL22 has been previously implicated in autoimmune diseases associated with WM pathology. The results suggest that an altered activation of innate immunity may contribute to WM damage in psychotic disorders.evel of ApoA-I was associated with smaller volume of the medial temporal WM. In whole-brain analyses, CCL22 correlated positively with mean diffusivity and radial diffusivity, and CXCL1 associated negatively with fractional anisotropy and positively with mean diffusivity and radial diffusivity in several brain regions. This is the first report to demonstratePeer reviewe

Synthetic lethal therapies for cancer: what's next after PARP inhibitors?

The genetic concept of synthetic lethality has now been validated clinically through the demonstrated efficacy of poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of cancers in individuals with germline loss-of-function mutations in either BRCA1 or BRCA2. Three different PARP inhibitors have now been approved for the treatment of patients with BRCA-mutant ovarian cancer and one for those with BRCA-mutant breast cancer; these agents have also shown promising results in patients with BRCA-mutant prostate cancer. Here, we describe a number of other synthetic lethal interactions that have been discovered in cancer. We discuss some of the underlying principles that might increase the likelihood of clinical efficacy and how new computational and experimental approaches are now facilitating the discovery and validation of synthetic lethal interactions. Finally, we make suggestions on possible future directions and challenges facing researchers in this field

The dynamics of the Cl+n-C4H10-->HCl (v',j') + C4H9 reaction at 0.32 eV.

Rotational state resolved center-of-mass angular scattering and kinetic energy release distributions have been determined for the HCl (v' = 0, j' = 0-6) products of the reaction of chlorine with n-butane using the photon-initiated reaction technique, coupled with velocity-map ion imaging. The angular and kinetic energy release distributions derived from the ion images are very similar to those obtained previously for the Cl plus ethane reaction. The angular distributions are found to shift from forward scattering to more isotropic scattering with increasing HCl rotational excitation. The kinetic energy release distributions indicate that around 30% of the available energy is channeled into internal excitation of the butyl radical products. The data analysis also suggests that H-atom abstraction takes place from both primary and secondary carbon atom sites, with the primary site producing rotationally cold, forward scattered HCl (v' = 0) products, and the secondary site yielding more isotropically scattered HCl (v' = 0) possessing higher rotational excitation. The mechanisms leading to these two product channels are discussed in the light of the present findings, and in comparison with studies of other Cl plus alkane reactions

The dynamics of the Cl+n-C4H10-->HCl (v',j') + C4H9 reaction at 0.32 eV.

Rotational state resolved center-of-mass angular scattering and kinetic energy release distributions have been determined for the HCl (v' = 0, j' = 0-6) products of the reaction of chlorine with n-butane using the photon-initiated reaction technique, coupled with velocity-map ion imaging. The angular and kinetic energy release distributions derived from the ion images are very similar to those obtained previously for the Cl plus ethane reaction. The angular distributions are found to shift from forward scattering to more isotropic scattering with increasing HCl rotational excitation. The kinetic energy release distributions indicate that around 30% of the available energy is channeled into internal excitation of the butyl radical products. The data analysis also suggests that H-atom abstraction takes place from both primary and secondary carbon atom sites, with the primary site producing rotationally cold, forward scattered HCl (v' = 0) products, and the secondary site yielding more isotropically scattered HCl (v' = 0) possessing higher rotational excitation. The mechanisms leading to these two product channels are discussed in the light of the present findings, and in comparison with studies of other Cl plus alkane reactions

The dynamics of the Cl+C2H6 -> HCl(v ',j ')+C2H5 reaction at 0.24 eV: Is ethyl a spectator?

The hydrogen atom abstraction reaction between Cl(2P3/2) and ethane was studied at a mean collision energy of 0.24 eV. Single beam experiments revealed both center-of-mass angular and energy release distributions